Login
Home
About Us
Services
Advances & More News
Medical News
Contact Us
Medical News
Reporting from AHA 2023: Etripamil Nasal Spray Outperforms Placebo for AFib with Rapid Ventricular Rate
Results of the phase 2 ReVeRA trial suggest use of etripamil nasal spray was associated with ...
read more
Directly from AHA 2023: Liberal Transfusion Strategy Could Improve Outcomes in Acute MI with Anemia
New data from a trial of more than 3500 patients suggests a more liberal transfusion strategy ...
read more
Diabetes Dialogue: SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023
With topline data announced in August and the full study released at the American Heart Association ...
read more
AHA 2023: Semaglutide 2.4 mg (Wegovy) Reduces Cardiovascular Risk in Overweight/Obesity with CVD
Results of the SELECT study confirm the cardiovascular benefit of semaglutide 2.4 mg (Wegovy) in people ...
read more
Broadcasting from AHA 2023: Study Highlights Limitations of ICD-10 Codes in Heart Failure Studies
Results of a study looking at International Classification of Diseases (ICD)-10 codes suggests researchers and clinicians ...
read more
Reporting from AHA 2023: Inflammation Could Be Better Predictor of Cardiovascular Events than LDL-C, Study Finds
Data from an analysis of more than 13,000 statin-intolerant patients is highlighting the impact of inflammation ...
read more
News Coverage from ACG 2023: RNA Stool Test Shows High Sensitivity for CRC Detection
A multi-target stool RNA test (mt-sRNA), also known as ColoSense, showed a high level of sensitivity ...
read more
Reporting from ACG 2023 - Uma Mahadevan, MD: Prioritizing Gastric Health in Gestational Patients
The findings from a new single-center study at the University of California, San Francisco (UCSF) highlighted ...
read more
First
Previous
1
2
3
4
5
...
Next
Last